Cas:5093-64-1 N-(5-Nitro-2-pyridinyl)acetamide manufacturer & supplier

We serve Chemical Name:N-(5-Nitro-2-pyridinyl)acetamide CAS:5093-64-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(5-Nitro-2-pyridinyl)acetamide

Chemical Name:N-(5-Nitro-2-pyridinyl)acetamide
CAS.NO:5093-64-1
Synonyms:N-(5-Nitro-2-pyridinyl)acetamide;MFCD00833973;Acetamide, N-(5-nitro-2-pyridinyl)-;N-(5-nitropyridin-2-yl)acetamide;2-Acetamido-5-Nitropyridine
Molecular Formula:C7H7N3O3
Molecular Weight:181.149
HS Code:2933399090

Physical and Chemical Properties:
Melting point:199-203 °C(lit.)
Boiling point:437.1±30.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.626
PSA:87.81000
Exact Mass:181.048737
LogP:1.14

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like N-(5-Nitro-2-pyridinyl)acetamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Acetamido-5-Nitropyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Acetamide, N-(5-nitro-2-pyridinyl)- Use and application,2-Acetamido-5-Nitropyridine technical grade,usp/ep/jp grade.


Related News: India and China are two of the leading players in that game, and US legislators for months have pushed for an aggressive “onshoring” of drug production to counteract the nation’s reliance on foreign producers. Israel, a key ally to the US, could be a logical partner in that effort, but the Trump administration also took out big bets on US firms to set up shop stateside. 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(3-((1-(2-(2,4-difluorophenyl)acetyl)piperidin-4-yl)methyl)phenyl)urea manufacturers “Partnering with a CDMO that has the skills and capabilities to execute a successful tech transfer is critical, as this complex, multi-step process helps lay the foundation for the new drug’s journey through to commercialization. 9,10-dimethoxy-2-trifluoromethyl-1,2,3,6,7,11b-hexahydro-pyrido[2,1-a]isoquinolin-4-one suppliers Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. 2-butylmercapto-benzoxazol-6-ylamine vendor & factory.